CLEVELAND, Ohio — Families can now test for flu, COVID-19 and respiratory syncytial virus with one at-home test. The ...

The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.

Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...

A collaboration between a rural, urgent care center network and diagnostics company may be laying the groundwork for speeding ...

Spending on respiratory pathogen testing at U.S. children’s hospitals has surged more than fourfold since 2016, as testing rates climbed from 13.6% of emergency department visits to 62.2% in 2022, ...

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Disease Testing Market by Test Type (Blood Tests, Imaging Tests, Pulmonary Function Tests), Component (Instruments, Reagents & Kits, ...

If proven to be accurate, the point-of-care test could provide the NHS with a highly scalable, low-cost diagnostic tool. It would help clinicians make faster decisions and improve patient care during ...

WHEN OSHA's revised Respiratory Protection Standard for General Industry, 29 CFR 1910.134, became effective on April 8, 1998, it provided employers with an all-inclusive reference source for fit ...

Influenza activity remains very high across Iowa, while COVID-19 and respiratory syncytial virus, or RSV, are circulating at ...

The respiratory pathogen testing kits market may rise from USD 4,304.6 Million in 2025 to USD 7,352.9 Million by 2035, with a CAGR of 5.5% over the forecast period. The global respiratory pathogen ...